• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Philip Brindle, England

      Philip Brindle, England

    • Ali Var, Turkey

      Ali Var, Turkey

    • Anna Barrow, UK

      Anna Barrow, UK

    • Michael Lee, Australia

      Michael Lee, Australia

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Chirag Walia, India

      Chirag Walia, India
      ChiragWalia

    • Steve

      Steve

    • Jorge Luis Fernández Romero, Mexico

      Jorge Luis Fernández Romero, Mexico

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Zabun Nassar, England

      Zabun Nassar, England

    • Malu Araujo Ribeiro, Brazil

      Malu Araujo Ribeiro, Brazil

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Sébastien Batiot, France

      Sébastien Batiot, France

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Carlos Alberto Arango, Colombia

      Carlos Alberto Arango, Colombia

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Roy Taylor, Ireland

      Roy Taylor, Ireland
      roy

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Karl Hughes, Ireland

      Karl Hughes, Ireland

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Ali Var, Turkey

      Ali Var, Turkey

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Jon Newsome, USA

      Jon Newsome, USA

    • Kirsten Harley, Australia

      Kirsten Harley, Australia

    • Maurice LeClerc, Canada

      Maurice LeClerc, Canada

    • Liam Dwyer, England

      Liam Dwyer, England

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • David Watson, Scotland

      David Watson, Scotland

    • Daniel Hare, USA

      Daniel Hare, USA

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Mike Small, UK

      Mike Small, UK

    • Cliff Marshman, USA

      Cliff Marshman, USA
      CliffMarshman

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Steven Gallagher, Canada

      Steven Gallagher, Canada

    • Mauril Belanger, Canada

      Mauril Belanger, Canada

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login